Roche and partner Klinrisk have picked up a CE-mark in the EU for an AI-based tool that can be used to predict renal function decline in patients with chronic kidney disease (CKD). The algorithm will ...
The proof-of-concept could pave the way for a new class of AI debuggers, making language models more reliable for business-critical applications.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback